Two high-profile cases in the pharma world have featured similar headlines this month—and they're not flattering to the legal profession. In both instances, allegations of attorney misconduct have shifted focus from the lawsuits themselves to the people arguing them.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,